Abstract:The COVID-19 pandemic caused by SARS-CoV-2 has posed unparalleled challenges due to its rapid transmission, ability to mutate, high mortality and morbidity, and enduring health complications. Vaccines have exhibited effectiveness, but their efficacy diminishes over time while new variants continue to emerge. Antiviral medications offer a viable alternative, but their success has been inconsistent. Therefore, there remains an ongoing need to identify innovative antiviral drugs for treating COVID-19 and its post-infection complications. The ORF3a (open reading frame 3a) protein found in SARS-CoV-2, represents a promising target for antiviral treatment due to its multifaceted role in viral pathogenesis, cytokine storms, disease severity, and mortality. ORF3a contributes significantly to viral pathogenesis by facilitating viral assembly and release, essential processes in the viral life cycle, while also suppressing the body's antiviral responses, thus aiding viral replication. ORF3a also has been implicated in triggering excessive inflammation, characterized by NF-κB-mediated cytokine production, ultimately leading to apoptotic cell death and tissue damage in the lungs, kidneys, and the central nervous system. Additionally, ORF3a triggers the activation of the NLRP3 inflammasome, inciting a cytokine storm, which is a major contributor to the severity of the disease and subsequent mortality. As with the spike protein, ORF3a also undergoes mutations, and certain mutant variants correlate with heightened disease severity in COVID-19. These mutations may influence viral replication and host cellular inflammatory responses. While establishing a direct link between ORF3a and mortality is difficult, its involvement in promoting inflammation and exacerbating disease severity likely contributes to higher mortality rates in severe COVID-19 cases. This review offers a comprehensive and detailed exploration of ORF3a's potential as an innovative antiviral drug target. Additionally, we outline potential strategies for discovering and developing ORF3a inhibitor drugs to counteract its harmful effects, alleviate tissue damage, and reduce the severity of COVID-19 and its lingering complications.

Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs

Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs

Cryo-electron Microscopy Structures of the SARS-CoV Spike Glycoprotein Reveal a Prerequisite Conformational State for Receptor Binding

Cryo-EM Structure of the SARS Coronavirus Spike Glycoprotein in Complex with Its Host Cell Receptor ACE2

SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity

The Open Reading Frame 3a Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Promotes Membrane Rearrangement and Cell Death.

CryoEM and AI Reveal a Structure of SARS-CoV-2 Nsp2, a Multifunctional Protein Involved in Key Host Processes.

Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane

Cryo-EM Structures Delineate a Ph-Dependent Switch That Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Structure and inhibition of SARS-CoV-2 spike refolding in membranes

Conformational Dynamics of SARS-CoV-2 Trimeric Spike Glycoprotein in Complex with Receptor ACE2 Revealed by Cryo-Em.

The SARS coronavirus accessory protein ORF3a rescues potassium conductance in yeast

SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects

A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles

Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel.

Computational Investigation of the Inhibitory Interaction of IRF3 and SARS-CoV-2 Accessory Protein ORF3b

Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EM